News & Perspective

Dec 06, 2017

Dec 06, 2017

News Scan for Dec 06, 2017

Boston BSL-4 lab OK'd
Zika infection patterns
Refugee diphtheria outbreak

Nov 11, 2014

Nov 11, 2014

News Scan for Nov 11, 2014

800th Saudi MERS case
Uganda Marburg outbreak over
H5N6 in poultry
Malaria control in Africa
Post-exposure BioThrax

Sep 11, 2014

Sep 11, 2014

News Scan for Sep 11, 2014

More Ebola in DRC
EV-D68 cases in 6 states
US HPV vaccine coverage
Anthrax vaccine contract
Marburg in Ugandan mine

Oct 10, 2012

Oct 10, 2012

Changes in select agent rules concern public health labs

(CIDRAP News) – The Centers for Disease Control and Prevention (CDC) has revised its list of potentially dangerous biological agents and toxins and the regulations covering them, and some of the changes have public health laboratories concerned.

Jun 15, 2011

Jun 15, 2011

Panel calls for refining, paring select-agent list

(CIDRAP News) – A federal advisory committee is recommending that 11 bacterial species and viruses on the current "select agent" list, including anthrax and Ebola virus, be singled out for special safeguards and that another 19 agents be dropped from the list entirely.

Oct 08, 2008

Oct 08, 2008

Two firms win NIAID support for Ebola-Marburg vaccines

(CIDRAP News) – Two biotechnology companies—Crucell, based in the Netherlands, and Integrated BioTherapeutics, based in Germantown, Md.—recently announced that they have received $30 million and $22 million contracts, respectively, from the National Institutes of Allergy and Infectious Diseases (NIAID) to develop single vaccines that would protect against both Ebola and Marburg viruses.

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»